DSM-Firmenich has agreed to pay $33 million to settle claims brought by direct purchasers in US litigation alleging price-fixing in the fragrance ingredients market. Direct purchasers have asked a New Jersey federal court to approve the proposed settlement with DSM-Firmenich and its subsidiaries. The agreement forms part of broader antitrust litigation concerning alleged coordination among major suppliers within the fragrance ingredient industry.
The settlement represents the latest development in a competition dispute that has followed the global fragrance supply industry for more than three years. In March 2023, competition authorities across the UK, European Union, Switzerland, and US began scrutinizing major fragrance suppliers over suspected anticompetitive conduct within the fragrance and fragrance ingredients market. The investigations examined allegations including coordinated pricing, restrictions on competitors supplying certain customers, and limitations on fragrance production.
Under the terms of the proposed settlement, DSM-Firmenich has also agreed to cooperate with the plaintiffs as the wider litigation continues. The settlement resolves the direct purchasers’ claims against DSM-Firmenich without establishing liability. The case puts renewed attention on competition within the fragrance ingredients supply chain, an industry dominated by a relatively small group of global suppliers responsible for developing and manufacturing many of the ingredients used across fine fragrance, personal care, and beauty products.
DSM-Firmenich is one of the world’s largest fragrance, flavors, and beauty ingredients businesses. The company was formed through the 2023 merger of Dutch health and nutrition group DSM and Swiss fragrance and flavor company Firmenich, bringing together operations spanning perfumery, beauty, nutrition, and ingredients.
The litigation follows heightened regulatory scrutiny of the fragrance sector in recent years. Competition authorities, including the UK’s Competition and Markets Authority and the Antitrust Division of the U.S. Department of Justice, have investigated whether companies operating within the market coordinated aspects of their commercial activities, raising questions about competition and pricing within an industry that sits largely behind the scenes of the global beauty business.
DSM-Firmenich is not the first major fragrance supplier to reach a financial agreement stemming from US litigation. International Flavors & Fragrances (IFF) agreed to a $26 million settlement with direct purchasers in 2025, while an additional $11 million settlement covering end-user plaintiffs was announced in May 2026. IFF has denied wrongdoing and, like DSM-Firmenich under the proposed agreement, agreed to cooperate with plaintiffs as other aspects of the litigation continue.
For beauty companies, the outcome is significant because fragrance suppliers occupy a critical position within the product development process. Major fragrance houses work across fine fragrance as well as scented skincare, haircare, bodycare, and personal care, meaning changes to ingredient pricing and competition can reverberate throughout the beauty supply chain.
The $33 million agreement does not bring the wider litigation to an end. DSM-Firmenich’s commitment to cooperate with plaintiffs means proceedings concerning other aspects of the alleged conduct can continue. Symrise, another major global fragrance and flavor supplier previously associated with the wider allegations, has been cleared and is no longer a defendant in the case.
The proposed settlement ultimately keeps the structure of the fragrance supply industry, and the pricing practices operating within it, under scrutiny at a time when fragrance remains one of beauty’s most commercially important categories.